The Effect of 5-hydroxytryptophan on ADHD Traits and Eye Movements

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Sheffield

About this trial

The aim of this project is to look at the impact of 5-Hydroxytryptophan (5-HTP) on distractibility. 5-HTP is the precursor to the neurotransmitter serotonin and is a chemical that the body produces naturally. There is evidence that distractibility is associated with a decreased level of serotonin. This research aims to see if giving people 5-HTP will alter their distractibility, which will form part of an initial assessment as to whether 5-HTP could be used to support people with attention problems. The study involves completing a short survey about mental health and behaviours, and if eligible, participation in an in-person study at the University of Sheffield. The in-person session involves completing some cognitive tasks to look at eye movement, taking 5-HTP or a sugar tablet with no active ingredients, and then completing the tasks again after a 90-minute wait.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

18-65 years of age

Normal or corrected to normal vision with contact lenses.

Score of <9 or >14 on the ASRS v5 (assessed in pre screen questionnaire)

Disqualifiers

Current use of psychostimulant medication or medication for the treatment of ADHD

Current use of medications known to impact the serotonergic system (e.g., SSRIs).

Smoking or vaping

Pregnancy

Trial design

Design model

Parallel

Treatments tested in this trial

  • 5-hydroxytryptophan (food supplement) 200mg

    Dietary supplement

    200mg 5-HTP delivered in two tablets. Tablets obtained from Nature's Best supplements. Each tablet contains 3982mg of Griffonia seed extract, providing 100mg of 5-HTP. The tablets consist of calcium carbonate, griffonia seed extract, Anti-caking Agents (Silicon Dioxide, Stearic Acid, \& Magnesium Stearate) and Tablet Coating (Hydroxypropyl Methylcellulose, Glycerol).

  • 5-hydroxytryptophan (food supplement) 300mg

    Dietary supplement

    300mg 5-HTP delivered in three tablets. Tablets obtained from Nature's Best supplements. Each tablet contains 3982mg of Griffonia seed extract, providing 100mg of 5-HTP. The tablets consist of calcium carbonate, griffonia seed extract, Anti-caking Agents (Silicon Dioxide, Stearic Acid, \& Magnesium Stearate) and Tablet Coating (Hydroxypropyl Methylcellulose, Glycerol).

  • Placebo

    Other intervention

    Unmedicated lactose-sucrose tablets provided by Ainsworth's homoeopathic remedies

Treatment groups

150 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Group A: High ADHD traits - 200mg 5-HTPExperimental treatment 1 intervention
Group B: High ADHD traits - 300mg 5-HTPExperimental treatment 1 intervention
Group C: High ADHD traits - PlaceboPlacebo comparator 1 intervention
Group D: Low ADHD traits - 200mg 5-HTPActive comparator 1 intervention
Group E: Low ADHD traits - 300mg 5-HTPActive comparator 1 intervention
Group F: Low ADHD traits - placeboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in distractibility - microsaccades

Frequency of microsaccades in a simple fixation task

Time frame
pre and 90 minutes post administration
2

Change in distractibility - reaction time

Measurement of reaction time on a visual search task with varying auditory stimuli.

Time frame
pre and 90 minutes post administration
3

Change in distractibility- fixations

Number of fixations on distractor letters in a visual search task with varying auditory stimuli.

Time frame
pre and 90 minute post administration

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.